A Bayer drug that hits two central nervous system targets to treat moderate-to-severe menopause symptoms has FDA approval, introducing a new non-hormonal therapeutic option that may have an advantage ...

The US Food and Drug Administration has approved another once-a-day pill that works without hormones to treat moderate to severe hot flashes in menopausal women, drugmaker Bayer said Friday. The drug, ...

The U.S. Food and Drug Administration has approved Lynkuet, a new daily pill from Bayer that provides a non-hormonal option for treating hot flashes, common during menopause. The drug, known ...

Dr. Céline Gounder, an internist, epidemiologist and infectious disease specialist, is a CBS News medical contributor as well as senior fellow and editor-at-large for public health at KFF Health News.

ACCORDINGLY. BACK TO YOU, MY FRIEND. THANKS, CORY. FOR MANY WOMEN, HOT FLASHES AND NIGHT SWEATS CAN MAKE MENOPAUSE A REAL CHALLENGE. THE FDA JUST APPROVED A NEW NON-HORMONAL DRUG TO HELP KOAT UNM ...

A decades-old warning rooted in flawed research kept millions of women from life-changing treatment, officials say.

The U.S. Food and Drug Administration will remove the “black box” warning labels on many hormone therapy drugs used for menopause and perimenopause symptoms — a major turnaround that’s likely to ...

Her brain, she tells SELF, “was like scrambled eggs.” She was in the throes of menopause symptoms that she’d expected to have ...

Add Yahoo as a preferred source to see more of our stories on Google. The U.S. Food and Drug Administration has approved Lynkuet, a new daily pill from Bayer that provides a non-hormonal option for ...

The U.S. Food and Drug Administration has approved Lynkuet, a new daily pill from Bayer that provides a non-hormonal option for treating hot flashes. The drug, known generically as elinzanetant, is ...